Parkinson's Flashcards

1
Q

What is the most important risk factor for Parkinson’s?

A

Age

Other risk factors include positive family history, male gender, environmental exposure (i.e. herbicide, pesticide, well water etc.), race, life experiences (i.e. trauma, emotional stress etc.)

Inverse correlation in smoking and caffeine intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is age the most important risk factor in PD?

A

Dopamine pathways are most affected by age

Normally a 10% loss of both dopamine and dopamine receptors per decade (but in PD it is an accelerated loss with threshold for onset at 80% loss)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the clinical symptoms versus the primary diagnostic criteria for PD?

A

Symptoms: resting tremor, bradykinesia, cogwheel rigidity, postural instability

Diagnostic features (TRABP): Tremor, Rigidity, Akinesia, Bradykinesia, Postural instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the Hoehn and Yahr Stages of Severity? (0-5)

A

0: No clinical signs evident
1: unilateral signs
2: bilateral signs without postural abnormalities
3: bilateral signs with mild postural imbalance or history of poor balance/falls (still independent pt)
4: bilateral signs with postural instability (assistance required)
5: severe, fully developed end stage disease (bedridden)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is PD diagnosed? What makes it challenging?

A

Hard to get definitive neurodiagnostic tests, mostly diagnosed through exclusion and only for sure post-mortem

Can do a drug challenge: if patient symptoms improve with levodopa or apomorphine then supports PD diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How might Parkinsonism be drug-induced?

A

Medications with an MOA involving reducing dopamine or blocking dopamine receptors can result in Parkinson symptoms or pseudoparkinsons i.e. anti-psychotics like phenothiazines and haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are the dopamine and acetylcholine system related?

A

In non-diseased state there is a balance between INHIBITORY dopaminergic and EXCITATORY cholinergic systems

In PD: loss of dopamine neurons in basal ganglia of substantia nigra results in loss of ability to control posture and initiate movment (dopamine is inhibitory in this pathway)…

Primary loss in dopamine leads to secondary increase in acetylcholine in basal ganglia (Ach is excitatory in this pathway)

So can try to block cholinergic effects in order to rebalance the decrease in dopaminergic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How was MPTP in the early 1980’s related to PD?

A

MPTP was added to heroin, MPTP is converted into MPP+ that is a toxin selective for dopaminergic neurons of substantia nigra = “frozen addicts” (induced Parkinsonism from permanent damage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Especially if onset is before 50 years old, what are the possible genes involved?

A
PARK1 = autosomal dominant, fast progression, Lewy-body Parkinsonism
PARK2 = autosomal recessive juvenile parkinsonism
PARK3 = 40% develop in 5th decade
PARK4 = develop between 30-60 years old
PARK5 = toxic protein aggregation (ubiqutin Carboxy-Terminal Hydroxylase)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does damage to the substantia nigra correlate to PD symptom development?

A

50%+ of neurons lost before onset of symptoms

Lewy bodies can appear in asymptomatic individuals but incidental Lewy body disease may indicate pre-symptomatic PD

Can use PET/SPECT imaging since preclinical disease is rarely identified by clinical assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the general mechanisms for PD treatment?

A
Increase endogenous dopamine (by inhibiting metabolism by dopa decarboxylase, COMT, or MAO B)
Use dopamine agonists (D1, D2, D3 or partial agonists)
Adenosine A2a (involved in dopamine release regulation in the brain)
Anticholinergics (since Ach and dopamine systems are correlated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does timing matter in providing drug therapy for PD?

A

Yes

Includes short-term relief for symptom control for ADL, and long-term management

Timing is based on patient functional ability and evolves as the disease progresses
Treatment should be titrated over time to maximize therapeutic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the ultimate goal of PD pharmacotherapy?

A

Slow or halt progression by replenishing dopamine (no cure though)

Also decreasing Ach may help with symptomatic tremor and rigidity (anticholinergics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LEVODOPA/Carbidopa (Sinemet)… this flash card specifically is talking about the levodopa component of Sinemet

A

This is the GOLD STANDARD for PD treatment (also is the most commonly prescribed remedy)

Mechanism: immediate precursor to dopamine and can cross the BBB, is taken up by dopaminergic presynaptic neurons in striatum, and converted to dopamine via aromatic L-amino acid decarboxylase

ADR: usually due to peripheral effects of dopamine (i.e. N/V, anorexia from stimulation of emetic center, tachycardia, arrythmias), CNS effects i.e. hallucinations, depression, DYSKINESIA etc.

Drug Interactions: vitamin B6/pyridoxine increases peripheral breakdown of Levodopa, MAOIs in combination can lead to HTN crisis from increased catecholamine production, antipsychotic meds are anti-dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is Levodopa (L-Dopa) given with Carbidopa?

A

Since some of the Levodopa is converted peripherally into dopamine, results in side effects

Needs Carbidopa as an enzyme inhibitor to minimize the 95% of the Levodopa would be metabolized in the periphery (without it, less than 5% reaches brain)

Take on empty stomach to increase absorption and transport across BBB (since has short half-life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is “wearing off” (or “end-of-dose wearing off”)?

A

Benefits of Levodopa get shorter over time with symptoms returning between doses, may mean disease is worsening

*Tolerance to Levodopa/Carbidopa usually develops after 3-5 years of therapy

17
Q

How can “wearing-off” be addressed?

A

Increase Levodopa dose or number of doses
Add a dopamine agonist or increase its dose
Use a COMT inhibitor (to decrease dopamine breakdown)

18
Q

What is Carbidopa mechanism of action and ADR?

A

Inhibits aromatic L-amino acid decarboxylase by binding to the pyridoxal binding site of the enzyme

Blocks enzyme in periphery but not CNS, which makes Levodopa more bioavailable for the CNS specifically

Reduces amount of Levodopa needed by 75% and reduces N/V and bad effects on the heart (75mg of Carbidopa needed to prevent peripheral ADRs)

ADR: increases incidence/severity of behavioral ADR from L-Dopa, increases dyskinesias from L-Dopa

19
Q

What do direct dopamine agonists do for PD and name the examples?

A

Direct stimulation of dopamine receptors (and can be used alone or with Carbidopa/Levodopa)

i.e.
Pergolide (full D2 partial D1; FDA withdrawn due to heart valve damage)
Cabergoine (D2 not FDA indicated for PD)
Bromocriptine (full D2; high 1st pass metabolism and protein binding with 3hr half-life)
Pramipexole (D2; renal excretion with 8-12hr half-life)
Ropinirole (D3>D2>4; CYP1A2 metabolism with 6hr half-life)
Apopmorphine (D4>D2, D3, D5>D1)

20
Q

What are the advantages of using dopamine agonists for PD as opposed to Levodopa/Carbidopa?

A

May beneficial as monotherapy in early PD (FDA indicated for Pramipexole and Ropinerole)

Less risk of motor complications and dyskinesias, increased symptom management, increased “time-on”, decreased need of Levodopa/Carbidopa

Potential neuroprotection (antioxidant properties… interacts with presynaptic dopamine receptors to decrease autooxidation/free radicals, decreased Levodopa requrements and toxic Levodopa metabolites)

21
Q

What are ADRs of dopamine agonists?

A

Similar to those of Levodopa
ADR often a limiting factor i.e. sedating effects, hypotension, hallucination/psychosis, possible dyskinesia, N/V, leg edema

Narcolepsy reported with Pramipexole and Ropinirole

Since may stimulate mesolimbic dopamine pathway/reward, there is potential for increased compulsive behavior i.e. gambling (treat by reducing DA agonist or switching to different DA agonist)

22
Q

Name a dopamine agonist that can be used transdermally

A

Rotigotine (Neupro)

Has high affinity for all dopamine receptor subtypes (D1/D2/D3)… but also means has potential for a lot of side effects peripherally due to affinity

Given once daily, can be monotherapy in early disease but is adjunctive therapy in advanced disease (useful for patients who can’t swallow)

Gives more continuous dopaminergic stimulation, good to lessen motor fluctuation and dyskinesias associated with PUSLATILE DA treatment long-term

ADR: site reaction, nausea, somnolence (serious if LOC while driving as shown in studies)

*possible to lower/maintain Levodopa doses theoretically when using a patch as supplement?

23
Q

Give examples of MAO-B inhibitors that can be used to treat PD

A

Selegiline
Rasagiline
Emsam

24
Q

Selegiline (Deprenyl, Eldepryl)

A

Mechanism: IRREVERSIBLE MAO-B inhibitor, blocking dopamine breakdown can extend L-Dopa actions up to 1hr or the time before L-Dopa is needed by 9 months

Indications: for patients with intact cognition and with “wearing off”

ADR: insomnia, jitteriness, HTN, worsened preexisting symptoms like hallucination/delusion
If used with SSRI then rarely may get serotonin syndrome (SSRI used to treat depression, commonly found in people with PD)

*Inconclusive evidence that it slows PD progression

25
Q

Ensam (transdermal Selegiline) can be used for what?

A

For adjunctive treatment of PD at low dose

26
Q

Rasagiline (Azilect)

A

Mechanism: SELECTIVE, irreversible MAO-B inhibitor (so is 5x more potent than Selegiline)

Indication: for 1st time treatment in patients with early PD, or as adjunct to Levodopa in patients with moderate to advanced PD

Metabolism: CYP 1A2

27
Q

Amantadine (Symmetrel, Symadine)

A

Mechanism: unknown… likely enhances synthesis and release of dopamine, inhibits dopamine reuptake, blocks cholinergic receptors, and inhibits NMDA receptors

Indications: adjunct to L-dopa
(Not as good as L-dopa but slightly better than anti-Ach agents)
Can relieve symptoms of bradykinesia, rigidity and tremor

ADR: less severe than L-dopa and anti-Ach agents (i.e. insomnia, dizziness, slurred speech)
Increased risk if given with anti-Ach agents (i.e. hallucination, confusion, nightmares)
*Should not give to patients with renal disease

28
Q

When are COMT inhibitors indicated for PD?

COMT = catochol-O-methyltransferase inhibitors

A

Never for monotherapy

Mechanism: blocks the metabolism of dopamine and inhibits COMT peripherally and centrally
Reduces the concentration of 3-O-methyltopa (which competes with L-Dopa for active transport)… this results in increased Levodopa bioavailability in the brain
(3-O-MD is a harmful metabolite of L-Dopa)

Indications: for patients on Levodopa with “wearing off”

29
Q

Tolcapone (Tasmar)

A

COMT inhibitor peripherally and centrally in nervous system

Indicatoin: start with Sinemet (Levadopa/Carbidopa)

Metabolism: readily absorbed, 99% protein bound, need strict liver function test monitoring since is hepatotoxic (stop if in liver failure)

ADR: delayed onset diarrhea, brown-orange fluid discoloration, orthostasis, hepatotoxicity

30
Q

Entacapone (Comtan)

A

COMT inhibitor (peripherally only)

Indication: Give with Levodopa/Carbidopa as adjunct to prevent peripheral conversion of Levodopa into its metabolite (this should prolong the effect of Levodopa and decrease the amount needed)

ADR: diarrhea, brown-orange urine discoloration, orthostasis, no evidence of hepatotoxicity

*Stalevo = combo drug of Carbidopa, Levodopa, and Entacapone)

31
Q

What kind of drugs are Trihexphenidyl (Artane) and Benztropine (Cogentin)?

A

Anti-cholinergics (but aren’t as effective as L-Dopa for managing PD)

Indications: can be effective against tremor and dystonia; usually ineffective against bradykinesia and other disabilities

ADR: (often limits use)
Sedation, memory impairment, dysphoria, hallucinations and confusion
Also antimuscarinic effects (i.e. dry mouth, blurry vision, constipation, urinary retention)

32
Q

What is a potential surgical therapy for PD?

A

Deep Brain Stimulation (DBS) is the most commonly performed for PD

Implant electrode connected to a pulse generator; can adjust amplitude, freuqency and pulse width

Deliver current to thalamus, globus pallidus interna or subthalamic nucleus

33
Q

What might be contributing factors to psychosis in patients with PD?

A

Risk factors: age, severe illness, cognitive impairment, depression and insomnia

Potentially due to certain triggers i.e. infection, electrolyte imbalance, sleep disorder

May be dopamine or Ach drug induced

34
Q

How can psychosis in PD patients be managed?

A

Avoid triggers

Minimize polypharmacy (anticholinergics, antidepressants, anxiolytic sedatives)
Reduce antiparkinsonian medications

Add atypical antipsychotics

Add cholinesterase inhibitor (i.e. Donazepril, Rivastigmine) if patient has dementia
(even though this actually has the opposite effect of desired PD treatment…since you do not want more Ach for PD)

35
Q

Why might giving atypical antipsychotics to manage psychosis actually worsen PD? Give examples

A

They are tight-binding dopamine antagonists

i.e. Quetiapine (Seroquel), or Clozapine (Clozaril) which also requires CBC to check for agranulocytosis

36
Q

If depression is significant in PD patient, how might it be treated?

A

Can use an SSRI or TCA
Can use any antidepressant but seems like DA agonist is suggested (possibly bc is better for geriatrics not necessarily for PD)

Hard to diagnose because symptoms overlap between depression and PD

Make sure to also evaluate electrolytes, thyroid and hypogonadism (males)…
Also should suggest sleep, nutrition and exercise